Finally, the findings were not validated in an external cohort, and larger, prospective, and multicenter studies with longitudinal biomarker profiling and standardized treatment protocols are needed to confirm the diagnostic and prognostic utility of IL-18 and other cytokines in sepsis. This evidence concerns the gene IL18 and Sepsis.